| A |
|
A Baltic Origin of the Common ADAMTS13 Mutation 4143insA
|
| Schneppenheim R, Kremer Hovinga JA, Budde U, Karpman D, Brockhaus W, Korczowski B, Milosevic D, Oyen F, von Rosen J, Tjønnfjord GE, Pimanda JE, Lämmle B |
| |
|
A Calcium-dependent Anti-human Coagulation Factor IX Monoclonal Antibody That Recognizes Phospho-serine (158) of the Activation Peptide Region
|
| Atoda H, Yokota E, Morita T |
| |
|
A Case of Non-Resolving Hemophilia B Leyden in a 40 year Old Male (Factor IX promoter +13 A to G)
|
| Stakiw JL, James PD, Leggo J, Walker I, Lillicrap D |
| |
|
A Case of Pseudotumor Cerebri in a Patient with Thrombophilia
|
| Rott H, Halimeh S, Kappert G, Trobisch H |
| |
|
A Characterization of Patients with Symptomatic DVT in India
|
| Turpie AGG |
| |
|
A Chromogenic Anti-FIIa Assay for the Assessment of Melagatran Activity in Plasma
|
| Reber G, de Moerloose P |
| |
|
A Chromogenic Method with High Resolution for Determination of Human FIX Activity in Purified Preparations
|
| Rosén S, Andersson M |
| |
|
A Common Ancestral Glycoprotein (GP) IX Gene Mutation (Asn45Ser) Causes Bernard-Soulier Syndrome (BSS) in European Families from Northern Europe and Australia
|
| Liang HPH, Morel-Kopp MC, Clemetson KJ, Kekomaki R, Kroll H, Michaelides K, Tuddenham EGD, Vanhoorelbeke K, Ward CM |
| |
|
A Common Pathogenetic Link between Venous Thrombosis and Atherosclerosis: Increased Prevalence of Small, Dense LDL
|
| Simioni P, Zambon A, Bertocco S, Tormene D, Polentarutti V, Fadin M, Perlati M, Prandoni P, Pagnan A |
| |
|
A Comparison between Venometry and D-Dimer in Screening for Deep Vein Thrombosis
|
| Williams D, Webster J, Watson HG |
| |
|
A Comparison of Calibration Curves Using Unfractionated Heparin, Enoxaparin, Dalteparin, and Fondaparinux in a Chromogenic Anti-FXa Assay
|
| Bethel M, Adcock DM, Ramanathan R |
| |
|
A Comparison of Enoxaparin and Unfractionated Heparin in Combination with Tirofiban during Percutaneous Coronary Intervention: Effects on Inhibition of Coagulation
|
| Perrin E, Ray M, Wood P, Walters D |
| |
|
A Comparison of Patients with DVT in Asia and Europe/Australia: Findings from the PROVE Registry
|
| Turpie AGG, the PROVE Investigators |
| |
|
A Comparison of the Canadian Hemophilia Outcomes – Kids Life Assessment Tool (CHO-KLAT) and the HaemoQoL
|
| McCusker PJ, Wakefield CD, Bradley CS, Barnard D, Blanchette VS, Young NL |
| |
|
A Comparison of the Effects of Shear Stress on the Interactions between Streptococcus sanguis and Staphylococcus aureus with Perfused Human Blood Platelets
|
| Kerrigan SW, Douglas CWI, Meade G, Foster TJ, Cox DM |
| |
|
A Comparison of the Incidence of PFA-100® Aspirin Non-Responders with 3.2% and 3.8% Citrated Blood (with and without Addition of in Vitro Aspirin)
|
| Harrison P, Segal H, Silver L, Rothwell PM |
| |
|
A Comparison of the PK/PD of Tinzaparin in Pregnant Women and in Non-Pregnant Healthy Volunteers
|
| Smith MP, Nielsen J, Stinson JC, Elleman-Olesen M |
| |
|
A Comparison of Two Manufacturing Processes for an Antithrombin Concentrate
|
| Chenou C, Bihoreau N, Sauger A, Siret L, Just O, Chtourou S |
| |
|
A Concept for Preoperative Identification of Patients with Impaired Primary Hemostasis
|
| Koscielny J, Kalus U, Ziemer S, Radtke H, Sinha P, Salama A, Kiesewetter H |
| |
|
A Concept for Preoperative Management of Patients with Impaired Primary Hemostasis
|
| Koscielny J, Kalus U, Ziemer S, Radtke H, Sinha P, Salama A, Kiesewetter H |
| |
|
A Critical Role for 14-3-3 Protein in Regulating the VWF Binding Function of the Platelet Glycoprotein Ib-IX
|
| Dai K, Bodnar R, Berndt M, Du X |
| |
|
A Cytoplasmic Template for the Development of Beta3 Drug Therapeutics
|
| Haas TA |
| |
|
A Database of Deficiency-Causing Mutations and Polymorphisms in the Factor V Gene
|
| Vos HL |
| |
|
A Diagnostic Challenge: Occurrence of Acquired Haemophilia A in Two Patients on Warfarin Therapy
|
| Riddell A, Brooks S, Unadkat S, Brown SA, Lee CA |
| |
|
A Familial Platelet Function Disorder Associated with Abnormal Signaling Through the Glycoprotein VI Pathway
|
| Dunkley S, Arthur J, Evans S, Shen Y, Andrews R |
| |
|
A Fast Track Strategy for Managing Suspected Pulmonary Embolism (PE) in Outpatients
|
| Sandset PM, Ghanima W, Almaas V, Aballi S, Dörje C, Nielssen B, Holmen LO |
| |
|
A Gain of Function Mutation in aIIbb3 Results in a Glanzmann Thrombasthenia Phenotype
|
| Vanhoorelbeke K, Pareyn I, Melchior C, Plançon S, Margue C, Pradier O, Fondu P, Kieffer N, Deckmyn H |
| |
|
A Genome Search for Genetic Determinants That Influence Plasma Fibrinogen Levels
|
| Soria JM, Almasy L, Souto JC, Buil A, Lathrop M, Blangero J, Fontcuberta J |
| |
|
A Genome-Wide Linkage Scan for Homocysteine Levels Identifies Three Regions of Interest
|
| Vermeulen HHM, van der Vleuten GM, de Graaf J, Blom HJ, Hermus AR, Stalenhoef AF, den Heijer M |
| |
|
A Heterodimeric Metalloprotease from Vipera Lebetina Venom Induces Human Endothelial Cell Apoptosis
|
| Siigur E, TrummalTõnismägi KK, Aaspõllu A, Lopp A, Sillat T, Saat R, Kasak L, Tammiste I, Kogerman P, Kalkkinen N, Siigur J |
| |
|
A High Prevalence of Ankle Arthropathy in Mild and Moderate Haemophilia A in South Australia and a Threshold Effect of FVIII Level on Its Occurrence
|
| Ling M, Heysen J, Duncan EM, Beard M, Rodgers SE, Lloyd JV |
| |
|
A Historical Comparison of Danaparoid (with or without Coumarin) Versus Ancrod (with or without Coumarin), or Coumarin Alone, for the Treatment of Heparin-Induced Thrombocytopenia (HIT): Evidence That Treatment Experience Can Influence Choice of Anticoagulant Rather Than Approval Status
|
| Lubenow N, Warkentin TE, Greinacher A, Wessel A, Sloane DA, Krahn EL, Magnani HN |
| |
|
A Hypercoagulable State in Myeloperoxidase Deficient Mice
|
| Spronk HMH, Huugen D, Frederix K, Loubele S, van Oerle R, ten Cate H, Heeringa P |
| |
|
A Lower Calcium Concentration Prolongs More Frequently Dilute Prothrombin Time (dPT) of Patients with Lupus Anticoagulant (LA) and Anti-B2GPI Antibodies (aB2GPI)
|
| Martinuzzo M, Cerrato G, Adamczuk Y, Iglesias Varela ML, Forastiero R |
| |
|
A Mechanism of Impaired Platelet Response to ADP Stimulation in the CLIC1 Knockout Mice
|
| Jiang L, Kuffner T, Qiu MR, Joseph J, Low J, Matthaei K, M.-Smith M, Curmi PMG, Breit SN |
| |
|
A Minor Variation of the APTT Mixing Test Can Be Used to Identify Defects in the Contact Mechanism
|
| Exner T, Low J, Joseph JE |
| |
|
A Missense Mutation in Exon 28 (C4120T) of the Von Willebrand Factor Gene is the Cause for Von Willebrand Disease in a Large Amish Pedigree
|
| Di Paola J, Murray J, Lentz S, Montgomery R, Sayago C, Wang K, Burns T, Shapiro A |
| |
|
A Model of Femoral Arterial Stenosis to Evaluate Anti-platelet Drugs in Baboons
|
| Meiring SM, Lamprecht S, Roodt J, Badenhorst PN |
| |
|
A Model Thrombus System for Assessing Thrombolysis
|
| Mutch NJ, Moore NR, Booth NA |
| |
|
A Monoclonal Antibody Against Platelet GPVI Impaires the Interaction Between Platelet and Collagen
|
| Yu Z, Dong N, Bai X, Shen F, Shao B, Ji S, Ruan C |
| |
|
A Monoclonal Antibody to High Molecular Weight Kininogen Reduces Inflammation in the HLA-B27 Transgenic Rat Model of Inflammatory Bowel Disease and Arthritis
|
| Colman RW, Keith JC, Jr2 , Sainz IM, Isordia-Salas I, Leathurby Y, Pixley RA, Albert LM |
| |
|
A Monoclonal Anti-C5 Antibody Reverses Antiphospholipid Antibody-mediated Thrombosis
|
| Pierangeli SS, Girardi G, Vega-Ostertag ME, Liu X, Salmon J |
| |
|
A Multicenter Controlled Trial of Anticoagulation Patient Self-Management in Germany Using the Protime System
|
| El Rouby S, for the German ProTime Study Group: Völler, H , Hartwig I, Kadar J, Dovifat C, Taborski U, Wegscheider K, Zucker ML, LaDuca FM, Ansell J |
| |
|
A Multicenter, Prospective Validation of Disseminated Intravascular Coagulation Diagnostic Criteria for Critically Ill Patients: Comparing Current Criteria
|
| Satoshi G, Shigeatsu E |
| |
|
A Multi-centre Assessment of the Chromogenic Method for Factor VIII:C Estimation in Plasma-derived and Recombinant Concentrates
|
| Hubbard AR, Barrowcliffe TW, Dodt J, Grancha S, Helgeson E, Jorquera JI, Metzner H, Mikaelsson M, Oswaldsson U, Smith G, Turecek PL, Seitz R |
| |
|
A Multicentre Study on 50 Cases with Thrombotic Thrombocytopenic Purpura in the Czech Republic: Recurrent Mutation in ADAMTS13 Gene as a Cause of a Hereditary Thrombotic Thrombocytopenic Purpura
|
| Hrachovinová I, Salaj P, Rittich [Scaron], Suttnar J, Dyr JE, Jinoch P, [Scaron]uláková T, Pták J, Ďulí[ccaron]ek P, Seeman T |
| |
|
A Multi-Dose Pharmacokinetic Study of Dalteparin in Hemodialysis Patients
|
| O'Shea SI, Perry SL, Byrne S, Szczech L, Ortel TL |
| |
|
A Multi-instrument Evaluation of a Chromogenic Factor X Assay for Monitoring Oral Anticoagulation Therapy
|
| Shaklee P, McGlasson D |
| |
|
A Multi-Rule Expert System to Manage OAT in Most Real-Life Clinical Situations
|
| Bal dit Sollier C, Cambus F, Mahé I, Siguret V, Gouin I, Drouet L, Cambus JP |
| |
|
A Mutation in Vitamin K Epoxide Reductase Complex Subunit-1 (VKORC1) in a Patient with Vitamin K Antagonist Resistance
|
| Bodin L, Samama MM, Horellou MH, Parent F, Flaujac C, Beaune P, Loriot MA, Conard J |
| |
|
A Naturally Occurring Leu33Val Mutation In Beta3 Integrin Impairs the HPA-1a Epitope and Receptor Function: The Third Allele of HPA-1
|
| Santoso S, Kroll H, Andrei-Selmer LC, Rankin A, Kretzschmar E, Watkins NA, Ouwehand WH |
| |
|
A Need for Standardisation in D-Dimer Testing: Evidence from a Collaborative Study by the UK NEQAS and QMP-LS Quality Assessment Programmes
|
| Jennings I, Raby A, Kitchen S, Woods TAL, Kitchen DP, Crowther M, Walker ID, Preston FE |
| |
|
A Negative Venous Duplex Ultrasound Scan Alone Excludes Deep Venous Thrombosis in Clinical Practice
|
| Gibbs H, Hetherington R, Gibb S, Catchpole I |
| |
|
A New Approach for Pre Analytical Screening of Hospitalized Patients Receiving Anticoagulant Therapy
|
| Katz B, Kirgner I, Zwang E, Vardimon H, Goncharov I, Mar-Zeev P, Deutsch V |
| |
|
A New Automatic Method to Measure Adamts 13
|
| Lattuada A, Preda L, Sacchi E, Candolfi R, Rossi E |
| |
|
A New Double Virus Inactivated 4-Factor Prothrombin Complex Concentrate (4F PCC)
|
| Griffin B, Murphy A, Stefaniuk K, Foster P, Morrison L, MacGregor I, Bienek C |
| |
|
A New Form of Familial Thrombocytopenia Associated with a Mutation of Cytochrome C
|
| Morison IM, Cheong PL, Holyoake AJ, Fichelson S, Cramer EM, Cheesman EJ |
| |
|
A New Fully Automated Functional Assay for TAFI Determination – STA® Stachrom® TAFI
|
| Beltran J, Combot C, Grosley M, Nicham F, Woodhams B |
| |
|
A New Functional Role of the Fibrinogen RGD Motif as the Molecular Switch that Selectively Triggers Integrin aIIbb3-Dependent Cell Spreading, but not Cell Attachment
|
| Salsmann A, Schaffner-Reckinger E, Kabile F, Margue C, Plançon S, Kieffer N |
| |
|
A New Method to Measure P2Y12 Receptor Expression on the Surface of Human Platelets: Effect of Clopidogrel
|
| Udaya T, Kevin PB, Jason Y, Kevin H, Rolf K, Paul AG |
| |
|
A Normal D-dimer and a Low Clinical Probability Test Safely Excludes Venous Thromboembolism. A Follow-up D-dimer Adds No Further Information
|
| Ljungqvist M, Ahlgren A, Moritz P, Söderberg M, Lärfars G |
| |
|
A Novel Anticoagulant Protein – Hemextin A, from the Venom of Hemachatus Haemachatus (African Ringhals Cobra) That inhibits the Extrinsic Tenase Activity and Its Synergistic Interaction with A Three-finger Toxin, Hemextin B
|
| Banerjee Y, Kini RM |
| |
|
A Novel Anti-LIBS mcAb (3C7) Is Specific for the Complex of Integrin aIIbb3 and Inhibits Platelets Aggregation and Adhesion
|
| Liu J, Chen P, Sun C |
| |
|
A Novel Case of Familial Thrombocytopenia with Evidence for a Critical Role of Proteins Involved in Ca2+ Signaling in Megakaryocytopoiesis
|
| Nurden P, Debili N, Vainchenker W, Hillman A, Bobe R, Pasquet JM, Bredoux R, Corvazier E, Nurden A, Enouf J |
| |
|
A Novel Coupled Enzymatic Assay for the Fast Kinetic Characterization of Synthetic and Physiological CPU (TAFIa) Substrates
|
| Willemse J, Leurs J, Verkerk R, Hendriks D |
| |
|
A Novel Cytokine Mediated Route of Promoting the Adhesion of Platelets to Endothelial Cell Monolayers
|
| Tull S, Anderson S, Hughan S, Watson S, Nash G, Rainger GEd |
| |
|
A Novel Deletion Mutation of Von Willebrand Factor Associated with Type 3 Von Willebrand Disease
|
| Dong N, Su J, Liu F, Zhao X, Ruan C |
| |
|
A Novel Fibrinogen Variant (Fibrinogen Seoul II: AaGln328Pro) with Impaired Fibrin Aa-chain Cross-linking
|
| Park R, Song K, Doh H, Chung K, An S |
| |
|
A Novel Homozygous Mutation (1619delC) in GPIIb Gene Associated with Glanzmann Thrombasthenia, the Decay of GPIIb-mRNA and the Synthesis of a Truncated GPIIb Unable to Form Complex with GPIIIa
|
| Losonczy G, Rosenberg N, Kiss C, Kappelmayer J, Vereb G, Kerenyi A, Balogh I, Muszbek L |
| |
|
A Novel Immunomodulatory Regime for the Eradication of Inhibitors to Factor VIII in a Severe Haemophiliac
|
| Hawkins SF, West S, Keenan R |
| |
|
A Novel Integrin aIIbb3-Associating Protein in Platelets
|
| Brophy T, Culligan K, Moran N |
| |
|
A Novel Mechanism of Action of Clopidogrel: Inhibition of Monocyte Procoagulant Activity
|
| Linden MD, Frelinger AL, Barnard MR, Furman MI, Michelson AD |
| |
|
A Novel Method for Determination of Human Plasma Plasminogen Activator Inhibitor (PAI-1)
|
| Crandall DL, Antrilli TM, Bauer JS, Day D |
| |
|
A Novel Molecular Marker of Soluble Fibrin Monomer-Fibrinogen Complex Is Quite Valuable for Diffrential Diagnosis of Septic Pneumonia and Simple Pneumonia
|
| Koga S, Tamimoto S, Nakahara K, Sakurai G, Matsuda M, Nakakuma H |
| |
|
A Novel Mutation (Asp36Tyr) in the Vitamin K Epoxide Reductase Complex Subunit 1 (VKORC1) Causes Moderately Increased Coumarin Doses
|
| Geisen C, Spohn G, Sittinger K, Rost S, Watzka M, Dimichele DM, Lages P, Huth-Kühne A, Zimmermann R, Müller CR, Seifried E, Oldenburg J |
| |
|
A Novel Mutation In Platelet Glycoprotein Iba Causing Bernard–Soulier Syndrome In A Bucharian Jewish Family
|
| Rosenberg N, Lalezari S, Shenkman B, Landau M, Seligsohn U, Izraeli S |
| |
|
A Novel Mutation in the Signal Peptide of the Antithrombin Gene
|
| Mellars G, Perry DJ |
| |
|
A Novel P-Selectin Inhibitor, PSI-697, Demonstrates Positive Activity Following Oral Administration in Rodent Models of Vascular Inflammation
|
| Bedard PW, Clerin V, Sushkova N, Darby A, DeBernardo S, Eppihimer MJ, Harding K, Janz K, Kaila N, Keith JC Jr, Tavares J, Schaub RG, Shaw GD |
| |
|
A Novel Role for Maternal Protein C in Embryonic Development
|
| Lay AJ, Liang Z, Rosen ED, Castellino FJ |
| |
|
A Novel, Specific and Quantitative Assay for Measuring Factor V-Leiden, with a Single Step Clotting Method
|
| Amiral J, Vissac AM |
| |
|
A Peptide Derived from Cytomegalovirus Reverses Antiphospholipid-Mediated Thrombosis by Displacing Binding of b2glycoprotein I to Endothelial Cells in Mice
|
| Vega-Ostertag ME, Liu X, Pierangeli S |
| |
|
A Phase II/III Clinical Study for the Determination of the Efficacy and Safety of Protein C Concentrate in Subjects with Severe Congenital Protein C Deficiency – Interim Study Analysis
|
| Gelmont D, Hays T, Bomgaars L, Palascak J, Shapiro A, Geil J, Montgomery J, Fritsch S, Maritsch F, Pavlova B, Ehrlich HJ |
| |
|
A Pilot Study of a DNA Microarray-Based Approach for the Screening of Mutations in Hemophilia A
|
| Berber E, Leggo J, Brown C, Hough C, Berber E, Gallo N, Feilotter H, Lillicrap D |
| |
|
A Positive Family History of Venous Thromboembolism Does Not Predict A High Risk of Recurrence
|
| Hron G, Eichinger S, Weltermann A, Minar E, Bialonczyk C, Hirschl M, Stain M, Schoenauer V, Kyrle PA |
| |
|
A Postmarketing Study of the Safety and Efficacy of ReFacto® in Haemophilia a Patients
|
| Smith MP, Giangrande P, Feingold J |
| |
|
A Prospective Cohort Study of Asymptomatic Individuals with Elevated Factor VIII : c to Determine the Absolute Incidence of Venous and Arterial Thromboembolism
|
| Bank I, Coppens M, Van de Poel MH, Hamulyák K, Prins MH, Van der Meer J, Büller HR, Middeldorp S |
| |
|
A Prospective Comparison of New Japanese Criteria for Disseminated Intravascular Coagulation. New Japanese Criteria vs. ISTH Criteria
|
| Hayakawa M, Gando S, Hoshino H |
| |
|
A Prospective Registry on the Long-Term Clinical Outcome of Venous Thromboembolism (Multicenter Advanced Study for a ThromboEmbolism Registry – MASTER): Description of the study cohort
|
| Agnelli G, Ageno W, Caponi C, Imberti D, Moia M, Palareti G, Pistelli R, Rossi R, Verso M |
| |
|
A Prospective Study to Assess the Absolute Incidence of Venous Thromboembolism (VTE) Associated with Hereditary Deficiencies of Protein C, Protein S and Antithrombin and the Contribution of Cosegregation of Other Thrombophilic Defects
|
| Brouwer JLP, Ten Kate MK, Veeger NJGM, Van der Schaaf W, Kluin-Nelemans HC, Van der Meer J |
| |
|
A Proteomics Approach for the Identification of Plasma Transglutaminase (FXIII) Substrates
|
| Howes J-M, Keen JN, Findlay JBC, Grant PJ, Carter AM |
| |
|
A Quantitative Trait Locus on Chromosome 12q14.1 Influences Plasminogen Levels in the San Antonio Heart Family Study (SAFHS)
|
| SantamaríaAlmasy AL, Rainwater DL, Mahaney MC, Comuzzie AG, Cole SA, Tracy RP, Stern MP, MacCluer JW, Blangero J |
| |
|
A Randomised Control Trial of Patient Self-Management of Oral Anticoagulation Compared with Patient Self-Testing
|
| Gardiner C, Williams K, Mackie IJ, Machin SJ, Cohen H |
| |
|
A Randomised Controlled Trial Comparing Warfarin and Phenprocoumon on Quality of Oral Anticoagulant Treatment
|
| Van Leeuwen Y, Van Der Meer FJM, Rosendaal FR |
| |
|
A Randomized Trial Comparing 1 mg Oral Vitamin K with Placebo for the Treatment of Warfarin-associated Coagulopathy in Patients with Mechanical Heart Valves
|
| Ageno W, Garcia D, Galli M, Silingardi M, Crowther M |
| |
|
A Rare Factor VIII Missense Variant as a Pitfall for Genetic Counseling
|
| Schneppenheim R, Schröder J, Obser T, Oyen F, Oldenburg J |
| |
|
A Rational Approach For Stabilization Of Activated TAFI (TAFIa)
|
| Ceresa E, Declerck PJ, Gils A |
| |
|
A Reduced VWF to FVIII Binding Capacity is not Uncommon in Patients With Type 1 Von Willebrand Disease: Results From the MCMDM-1VWD Study
|
| Goudemand J, Caron C, Federici A, Goodeve A, Castaman G, Mazurier C, Hilbert L, Peake I, Rodeghiero F, Battle J, Meyer D, Eikenboom J, Schneppenheim R, Budde U, Ingerslev J, Vorlova Z, Habart D, Holmberg L, Lethagen S, Pasi J, Hill F |
| |
|
A Role for Adipocyte-enriched Transcription Factor, PPAR-g, in Up-regulation of PAI-1 Gene Expression during Adipogenesis
|
| Ihara H, Loskutoff DJ, Urano T |
| |
|
A Role for Calpain in Store-Operated Calcium Entry in Human Platelets
|
| Harper AGS, Sage SO |
| |
|
A Second Swiss Family with Upshaw-Schulman Syndrome (Hereditary Thrombotic Thrombocytopenic Purpura, TTP): Clinical Course and Molecular Findings
|
| Kremer Hovinga JA, Mäder G, Lovey PY, Morris MA, Oppliger Leibundgut E, Kuchler H, Wermuth B, Lämmle B |
| |
|
A Sensitized Genome-Wide ENU Mutagenesis Screen in the Mouse to Identify Genetic Modifiers of Thrombosis
|
|
| |
|
A Sequence Derived from Loop I of PDGF Inserted into Neurotoxin Dendroaspin Scaffold Has an Ability to Inhibit Cell Proliferation and Migration
|
| Lu D, Xia M, Scully M, Kakkar V, Chung F, Lu X |
| |
|
A Short Tandem Repeat Polymorphism Leads to Differential Expression of the Neonatal Fc Receptor
|
| Sachs UJH, Braeunlich CG, Socher I, Bein G, Kroll H, Santoso S |
| |
|
A Simple Technique to Determine Thrombopoiesis Level Using Immature Platelet Fraction (IPF)
|
| Abe Y, Nishioka J, Wada H, Nobori T, Kobayashi T, Shiku H, Oguni S |
| |
|
A Single Preoperative dose of Tranexamic Acid Reduces Blood Loss and Heterologous Blood Transfusion in Radical Retropubic Prostatectomy
|
| Schött U, Jacobsson A, Ekström B, Annerstedt M |
| |
|
A Snake Venom Metalloproteinase, Kistomin, Cleaves Platelet Glycoprotein VI to Disrupt Platelet Function
|
| Hsu CC, Huang TF |
| |
|
A Spot Peptide Approach to Identify Binding Regions Between the TF-FVIIa Complex and its Macromolecular Substrates FIX and FX
|
| Giansily-Blaizot M, Pellequer JL, Schved JF, Granier C, Villard S |
| |
|
A Synthetic Peptide Derived From Thrombospondin-1 (TSP1) Type 3 Repeats Modulates Angiogenesis and the Disease Course in an Animal Model of Rheumatoid Arthritis (RA) by Down-Regulating Connective Tissue Growth Factor (CTGF) Expression
|
| Manns JM, Casteneda J, Rico M, Barbe MF, Safadi FF, Popoff SN, Uknis AB, DeLa Cadena RA |
| |
|
A System to Track Coagulation Factor Concentrates Can Decrease Waste
|
| Walker ••, Arnold D, Carruthers J, Almonte T, Chan A, Pai M, Goldsmith R, Seroski W, Decker K, Stiles C |
| |
|
A Telemedicine Project for Managing Patients on Oral Anticoagulant Therapy
|
| Testa S, Alatri A, Paoletti O, Morstabilini G |
| |
|
A Thirteen Year Retrospective Study of Inherited Bleeding Disorders in the Jordanian Population
|
| Eid S, Shubilat T, Abu-Ghoush M |
| |
|
A UK Survey of Prophylaxis in Paediatric Patients with Haemophilia
|
| Thomas A, Richards M, Leisner R, Chalmers E, Brown S, Vidler V, Pasi J, Williams M |
| |
|
A Unique Fusion Protein Combines Clot Targeting, Platelet Blockade and Direct Factor Xa Inhibition in One Molecule
|
| Schwarz M, Jaminet P, Herzog S, Bassler N, Bode C, Peter K |
| |
|
A2 Domain of Human Von Willebrand Factor Expressed in E. Coli and Its Use in Quantitative Measurement of ADAMTS13 Activity
|
| Bai X, Su J, GAO W, Liu F, Wang Z, Ruan C |
| |
|
ABCA1 Transporter and Paraoxonase Gene Polymorphisms in Myocardial Infarction and Stroke
|
| Pchelina S, Sheydina A, Rodygina T, Taraskina A, Schwarzman A |
| |
|
Abdominal Obesity and the Risk of Recurrent Deep Vein Thrombosis
|
| Romualdi E, Dentali F, Squizzato A, Galli M, Manfredi E, Vitale J, Cattaneo A, Steidl L, Ageno W |
| |
|
Ability of Different Glycoprotein IIb-IIIa (aIIb/b3-Integrin) Ligands to Support Platelet Aggregation and Release Reaction Induced by Activating Anti-LIBS Antibody
|
| Mazurov AV, Naimushin YA |
| |
|
Abnormal Kinetics of Fibrinolysis in Patients with Chronic Thromboembolic Pulmonary Hypertension
|
| Morris TA, Marsh JJ, Chiles PG, Auger WA |
| |
|
Abnormal Megakaryocyte Maturation, Abortive Platelet Shedding and inflammatory Disease Caused By Mutations in the Cytoskeletal Regulator Aip1
|
| Kile BT, Stirzaker RA, Justice MJ |
| |
|
Abnormal Multimeric Pattern Is Not Associated with Increased Bleeding Symptoms in Index Cases of Families with Type 1 VWD. Results from the EU MCMDM-1 VWD Study
|
| Castaman G, Tosetto A, Peake I, Goodeve A, Rodeghiero F, Federici A, Batlle J, Meyer D, Mazurier C, Goudemand J, Fressinaud E, Eikenboom J, Schneppenheim R, Budde U, Ingerslev J, Vorlova Z, Habart D, Holmberg L, Lethagen S, Pasi J, Hill F |
| |
|
ABO and Secretor Genotypes and the Risk of Pre-Eclampsia
|
| Clark P, O'Sullivan A, Forgan M, Campbell DM, Greaves M, Walker ID, Greer IA, Vickers MA |
| |
|
ABO Blood Group Genotypes and the Risk of Venous Thrombosis: Effect of Factor V Leiden
|
| Morelli VM, de Visser MCH, Vos HL, Eikenboom HCJ, Bertina RM, Rosendaal FR |
| |
|
Absence of Exon V Deleted Factor XI mRNA in Homozygous Factor XI Deficiency
|
| Mitchell M, Zivelin A, Savidge GF, Alhaq A |
| |
|
Absence of Interaction Between Influenza Vaccination and Oral Anticoagulant Therapy: A Randomized Blinded Clinical Trial
|
| Guercini F, Conti S, Ferrante F, Paccamiccio E, Iaboni S, Vecchioli M, De Punzio I, Basileo M, Camilloni B, Iorio AM, Iorio A |
| |
|
Absolute CD62 Expression and PAC-1 Binding Correlate with Decreased PFA-100 Closure Times Seen in Severely Injured Patients
|
| Gosselin R, Paglieroni TJ, Jacoby R, Janatpour K, Owings J, Larkin E |
| |
|
Absolute Incidence of Recurrent Venous Thromboembolism in Patients with Elevated Levels of Factor VIII : c
|
| Coppens M, Van der Poel MHW, Hamulyák K, Van der Meer J, Veeger NJ, PrinsBüller MHHR, Middeldorp S |
| |
|
Absolute Risk of Arterial Thromboembolism (ATE) Associated with Nephrotic Syndrome. Results from the Coltrane Study
|
| Vogt L, Brouwer JLP, Ten Kate MK, Van der Meer J, Navis GJ |
| |
|
Absolute Risk of Venous and Arterial Thromboembolism Associated with Mild Hyperhomocysteinemia. Results from a Retrospective Family Cohort Study
|
| Van de Poel MHW, Coppens M, Middeldorp S, Hamulyak K, Veeger NJGM, Prins MH, Büller HR, van der Meer J |
| |
|
Absolute Risk of Venous Thromboembolism (VTE) Associated with Hereditary Deficiencies of Protein C, Protein S or Antithrombin Strongly Depends on Cosegregation of other Thrombophilic Disorders. A Retrospective Family Cohort Study (DESCARTES)
|
| Brouwer JLP, Ten Kate MK, Veeger NJGM, Van der Schaaf W, Kluin-Nelemans HC, Van der Meer J |
| |
|
Absolute Risk of Venous Thromboembolism (VTE) Associated with Nephrotic Syndrome. Results from the Coltrane Study
|
| Vogt L, Brouwer JLP, Ten Kate MK, Navis GJ, Van der Meer J |
| |
|
Absolute Risk of Venous Thromboembolism (VTE) Associated with Oral Contraceptives in Women with Hereditary Deficiencies Of Protein S, Protein C or Antithrombin Strongly Depends on Cosegregation of Thrombophilic Disorders. A Retrospective Family Cohort Study (DESCARTES)
|
| Van Vlijmen EFW, Brouwer JLP, Veeger NJGM, De Graeff PA, Van der Meer J |
| |
|
Abstract withdrawn
|
|
| |
|
Abstract withdrawn
|
|
| |
|
Abstract Withdrawn
|
|
| |
|
Abstract Withdrawn
|
|
| |
|
Abstract Withdrawn
|
|
| |
|
Abstract withdrawn
|
|
| |
|
Abstract withdrawn
|
|
| |
|
Abstract withdrawn
|
|
| |
|
Accuracy and Precision of International Normalized Ratios (INRs) for Two Point of Care Test Systems: Comparison with Laboratory INR Monitoring
|
| Engelsen J, Nielsen JD |
| |
|
Accuracy of a Whole Blood D-Dimer Assay (SimplifyTM) for Deep Vein Thrombosis, When Performed Using Venous Whole Blood and Frozen Plasma in a Cohort Patients with Suspected Deep Vein Thrombosis
|
| Chunilal SD, Lake JD, Davey M, Spike J, Johanson S, Williams A, Kyriacou M, Charles P, Duncan E, Lloyd JV |
| |
|
Accuracy of Pretest Probability Assessment of Pulmonary Embolism by Junior Physicians Using the Explicit Wells Clinical Model
|
| Penaloza A, Melot C, Blocklet D, Gevenois PA, Wautrecht JC, Lheureux, Ph, Motte S |
| |
|
Accurate RNA Transcript Profiling of Platelets from Clinically Relevant, Small Blood Volumes
|
| Hillmann AG, Park SDE, Shields DC, Moran N, Kenny D |
| |
|
ACE DD Genotype: A Predisposing Factor to Abdominal Aortic Aneurysm
|
| Fatini C, Sticchi E, Lari B, Bolli P, Sofi F, Pratesi G, Pulli R, Pratesi C, Abbate R, Gensini GF |
| |
|
Acetaminophen Inhibits Platelet Function Dose-dependently in Volunteers
|
| Munsterhjelm E, Lundström NM, Niemi TT, Neuvonen PJ, Rosenberg PH |
| |
|
Acetylsalicylic Acid (ASA) Resistance in Patients with Ischemic Heart Disease (IHD) as Bioindicator of the Treatment Strategy
|
| Malý J, Pecka M, Pudil R, Gregor J, Malý R, Kopecký O, Duli[ccaron]ek P |
| |
|
Acquired Activated Protein C Resistance Associated with Pulmonary Arterial Hypertension Is Revealed by Calibrated Automated Thrombography
|
| Regnault V, Chabot F, Lecompte T |
| |
|
Acquired and Hereditary Thrombophilia and Recurrent Miscarriage
|
| Ulander V-M, Palosuo T, Kaaja R |
| |
|
Acquired Antithrombin Deficiency in Acute Lymphoblastic Leukaemia (ALL) Induced by L-Asparaginase (ASNase): A Conformational Mechanism Modulated by Dexamethasone
|
| Hernández-Espinosa D, Cano H, Heras I, Pérez-Ceballos E, Fuster JL, Bermúdez MM, Linares ME, Miñano A, Vicente V, Corral J |
| |
|
Acquired FXIII Deficiency in a Patient with Systemic Lupus Erythematodes: Clinical Presentation and Management
|
| Schlammadinger Á, AjznerMéhes ÉL, Papp M, Muszbek L, Udvardy M, Boda Z |
| |
|
Acquired Glanzmann's Thrombasthenia Associated with Trastuzumab (Herceptin®) Therapy: A Case Report
|
| Loreth RM, Pachmann U |
| |
|
Acquired Risk Factors Play a Major Role in Venous Thrombosis in Chinese Population
|
| Feng Y, Zhou X, Xiong X, Xiong Y, Wang Y, Jiang S, Hu H, Lu D, Wang Z |
| |
|
Acquired von Willebrand Syndrome Due to an Antibody Against von Willebrand Factor Associated to a Strong Platelet Thromboagglutinin Simulating a Type 2B von Willebrand Disease
|
| Bellucci S, Boval B, Caron C |
| |
|
Activated Carboxypeptidase N Is a Potent Antifibrinolytic Agent in Human Plasma
|
| Walker JB, Bajzar L |
| |
|
Activated Factor XI Cleaves von Willebrand Factor in the A2 Domain: A Possible Role of FXIa Along with ADAMTS13 in the Etiology of TTP
|
| Guinto ER, Grafos N, Ranzurmal S, Motto D, Greenfield RS |
| |
|
Activated Factor XII Provides Better Short-term Prognostic Information for a Subsequent Troponin-T Positive Event than other Biomarkers in Patients with Myocardial Infarction
|
| Pönitz V, Brügger-Andersen T, Pritchard D, Grundt H, Nilsen DW |
| |
|
Activated Human Platelets Synthesize Functional Tissue Factor
|
| Panes O, Matus V, Sáez CG, Quiroga T, Pereira J, Mezzano D |
| |
|
Activated Peripheral Mononuclear Cells Plus Soluble Plasma Tissue Factor (TF) Activate Factors VII and X in Cardiac Surgical Wounds
|
| Khan MM, Hattori T, Edmunds Jr. LH, Colman RW |
| |
|
Activated Protein C
|
| Griffin JH, Zlokovic BV |
| |
|
Activated Protein C (APC) Bound to Microparticle-Associated Endothelial Protein C Receptor (EPCR) Occurs in vivo and Has Anticoagulant Properties
|
| Pérez-Casal M, Downey C, Toh CH |
| |
|
Activated Protein C Resistance and Factor V Arg306Thr Mutation: A Case Report
|
| Le Cam-Duchez V, Chrétien MH, Saugier-Veber P, Deshayes A, Yastremsky F, Borg JY |
| |
|
Activation and Translocation of Tyrosine Phosphatase SHP-1 to Lipid Rafts Is P2X1 Mediated: Role in Collagen Induced Platelet Activation
|
| Hu H, Cludts K, Groeseneken T, Hoylaerts MF |
| |
|
Activation Hypothesis for Coagulation Factor VIIa
|
| Olsen OH, Ostergaard H, Stennicke HR, Andersen MD, Taboureau O, Persson E |
| |
|
Activation Kinetics of Glycoform of GLU-Plasminogen and Lys-Plasminogen by Plasmin-Staphylokinase Complex
|
| Aisina RB, Moukhametova LI, Gershkovich KB, Varfolomeyev SD |
| |
|
Activation of Factor VIII and Mechanisms of Cofactor Action
|
| Fay PJ |
| |
|
Activation of Fibrinolysis System at the Main Arterial and Venous Vessels Thrombosis with the Treatment of Gene-Engineering Thrombolythic Drug ‘Triasa’
|
| Kruchinsky N, Plenina L, Akulich N, Tepljakov A, Tsymanovich S |
| |
|
Activation of G12/13 Pathway is Essential for the Dense Granule Release in Platelets
|
| Jin J, Kim S, Kunapuli PS |
| |
|
Activation of MAP Kinase Pathway in Monocytes by TF/FVIIa is Required for TNF-a Production but not for PDGF-BB Induced Chemotaxis
|
| Johnell M, Siegbahn A |
| |
|
Activation of NF-kB by Reactive Oxygen Species Mediates Induction of PAI-1 Expression in Vascular Endothelial Cells
|
| Swiatkowska M, Szemraj J, Cierniewski CS, Liao JK |
| |
|
Activation of the Contact Factor System and Its Predictive Role in Coronary Heart Disease and Ischemic Stroke; Follow Up from the Second Northwick Park Heart Study
|
| Smid M, Govers-Riemslag JWP, Cooper JA, Hack CE, Fens D, Spronk HMH, Hamulyak K, Bauer KA, Rosenberg RD, ten Cate H, Miller GJ |
| |
|
Activation of the Fibrinolytic System by Amyloid Cross-b Structure Results In reply to: Cell Detachment AND Processing of Neuroendocrine Factors
|
| Bouma B, Kranenburg O, Schiks B, Romijn EP, Posthuma G, Kayed R, Heck AJR, Aarsman CJ, Gent YJJ, Voest EE, de Groot PhG, Gebbink MFBG |
| |
|
Active Metabolites of CS-747 (Prasugrel, LY640315) and Clopidogrel Show Similar in vitro P2Y12 Receptor Blockade But Greater in vivo Potency of CS-747
|
| Sugidachi A, Ogawa T, Hasegawa M, Nakanishi Y, Suzuki N, Kurihara A, Hagihara K, Jakubowski JA, Asai F |
| |
|
Active Von Willebrand Factor Is present in Plasma of Patients with Von Willebrand Disease Type 2B Or ADAMTS-13 Deficiency
|
| Hulstein JJJ, Lenting PJ, Silence K, Fijnheer R, de Groot PG |
| |
|
Activity and Content of Factor VIII in Various Factor VIII Products
|
| Butenas S, Parhami-Seren B, Gissel MT, Gomperts ED, Mann KG |
| |
|
Activity and Localization of Tissue Factor and Factor VII in Organs of Normal and Endotoxemic Mice
|
| Frederix K, Loubele S, Van Oerle R, Hamulyak K, Spronk HMH, Ten Cate H |
| |
|
Acute and Long Term Management for Patients with Severe Protein C Deficiency
|
| Chuansumrit A, Sirachainan N, Kanogsunthornrat N, Parapakpenjune S, Wongwerawattanakoon P |
| |
|
Acute Hyperglycemia Perturbs Endothelial Glycocalyx and Induces a Prothrombotic State in Healthy Volunteers
|
| Nieuwdorp M, van Lieshout MHP, Levi M, Hoekstra JBL, Meijers JCM, Vink H, van Haeften TW, Kastelein JJP, Stroes ESG |
| |
|
Acute Inhibitory Effects of Glycoprotein IIb/IIIa Receptor Blockers on Platelet Function During Percutaneous Coronary Intervention
|
| Han J, Park T, Park E, Kim H, Kim M |
| |
|
Acute Myocardial Infarction in Haemophillia A or B Patients: A Cardiological Evaluation of 44 Reported Cases
|
| Girolami A, Zanon E, Lombardi A, Sartori R, Girolami B |
| |
|
Acute Phase of Inflammation and Mortality in Elderly Patients with Pulmonary Embolism
|
| Masotti L, Cappelli R |
| |
|
Acute Treatment of Venous Thromboembolism (VTE) with Fixed-Dose, Weight-Adjusted, Unfractionated Heparin (UFH) Given Subcutaneously (sc) without Laboratory Monitoring: Randomized Comparison with Low-Molecular-Weight-Heparin (LMWH)
|
| Kearon C, Ginsberg JS, Julian J, Douketis J, Solymoss S, Ockelford P, Jackson S, Turpie AGG, McCarty D, MacKinnon B, Hirsh J, Gent M |
| |
|
ADAMTS 13 Activity and VWF : Ag Levels in Patients with Ischemic Stroke
|
| Krause M, Böhm M, Stier-Brück I, Scharrer I |
| |
|
ADAMTS-13 Activity Profile in Thrombotic Thrombocytopenic Purpura (TTP) Patients Prospectively Followed At A Single Centre
|
| Falanga A, Marchetti M, Balducci D, Russo L, Vignoli A, Finazzi G, Barbui T |
| |
|
ADAMTS13 Forms a Stable Complex with Coagulation Factors XI (FXI) and Activated FXI (FXIa): Quantitation of ADAMTS13/FXI Complexes in Normal Plasma and in Thrombotic Thrombocytopenia Purpura (TTP) Plasmas Using a New ELISA
|
| Ranzurmal S, Grafos N, Guinto E, Greenfield RS |
| |
|
ADAMTS13 Gene Mutations and Polymorphisms in Acquired Thrombotic Thrombocytopenic Purpura (TTP) Patients
|
| Camilleri RS, Mackie IJ, Scully M, Machin SJ, Cohen H |
| |
|
ADAMTS13 Is Present in Human Platelets and Strongly Expressed on COAT-Platelets
|
| Colucci G, Kremer Hovinga J, Sulzer I, Lämmle B, Alberio L |
| |
|
ADAMTS13 Substrate Recognition of the Von Willebrand Factor A2 Domain
|
| Zanardelli S, Chan Kwo Chion A, Preston RJS, Lane DA, Crawley JTB |
| |
|
Additional Environmental and Genetic Factors Are Required to Trigger TTP in ADAMTS13-Deficient Mice
|
| Motto D, Zhu G, Homeister J, Ginsburg D |
| |
|
Adenovirus Urokinase (uPA) Gene Transfection Mediates Monocyte Fibrinolysis
|
| Humphries J, Gossage J, Murdoch C, Burnand K, Smith A |
| |
|
Adenovirus-Mediated Transfer of Human Placental Ecto-Nucleoside Triphosphate Diphosphohydrolase to Vascular Smooth Muscle Cells Suppresses Platelet Aggregation in vitro and Arterial Thrombus Formation in vivo
|
| Furukoji E, Matsumoto M, Yamashita A, Yagi H, Sakurai Y, Marutsuka K, Hatakeyama K, Morishita K, Fujimura Y, Tamura S, Asada Y |
| |
|
Adenovirus-Mediated VEGF Gene Therapy Enhances Venous Thrombus Resolution
|
| Modarai B, Burnand KG, Afuwape A, Humphries J, Gossage J, Paleolog E, Smith A |
| |
|
Adhesion Molecules and Leukocyte Migration in the Context of Corneal Wound Healing
|
| Smith CW, Burns AR, Li Z |
| |
|
Adhesive Properties and Fibrinolytic Response of Endothelial Cells Containing PAI-1 in the Complex with Alpha 1-Acid Glycoprotein Accumulated on Their Surface
|
| Boncela J, Smolarczyk K, Cierniewski CS |
| |
|
Adhesive Surface Determines Raft Composition in Platelets Adhering Under Flow
|
| van Lier M, Verhoef S, Lee F, Farndale RW2 , Gorter G, Ohno-Iwashita Y, Akkerman JWN, Heijnen HFG |
| |
|
Adiponectin Correlation with Plasma Lipoprotein Subclasses Determined by NMR and with the Risk of Venous Thrombosis
|
| Fernández JA, Deguchi H, Pecheniuk NM, Elias DJ, Griffin JH |
| |
|
Adjunctive Use of Anticoagulants with a TAFIa Inhibitor Does Not Further Enhance t-PA-Induced Thrombolysis in a Rabbit Arterial Thrombosis Model and Compromises Safety
|
| Klement P, Liao P, Chen F, Weitz J |
| |
|
Administration of Recombinant Activated Factor VII Causes Activation of Integrin aIIbb3 on Blood Platelets both in vivo and in vitro, Lowering the Threshold for Activation by Thrombin
|
| Mathijssen NCJ, van Beurden-Lourenssen GJACM, Verbruggen HW, van Kraaij MGJ, Nováková IRO, van Heerde WL |
| |
|
Adrenergic and Cholinergic Regulation of Local t-PA Release in Human Vasculature
|
| Giannarelli C, Taddei S, De Negri F, Virdis A, Cipriano A, Carmassi F, Salvetti A |
| |
|
Adult Non-Twin Sib Concordance Rates for Non-Insulin Dependent Diabetes Mellitus (NIDDM) and Hypertension in Asian Indian Population
|
| Shankar J, Mukherjee M, Kanjilal S, Rao VS, Iyengar SS, Kakkar VV |
| |
|
Advanced Glycation End Products Upregulate Endothelial COX-2 Expression and Induce Aspirin Resistant Thromboxane Synthesis by Platelets
|
| Murasaki K, Tanoue K, Omori H, Kasanuki K |
| |
|
Advances in Genetics of Thrombosis and MI
|
| Wang Q |
| |
|
ADVOY: First Experiences with an Internet Based Electronic System for Documentation of Haemophilia Therapy of Patients in Home Treatment
|
| Siegmund B, Pollmann H |
| |
|
Affinity Maturation of Blocking Human Antibodies Against Human Glycoprotein VI
|
| Davies LW, O'Connor MN, Smethurst PA, Farndale RW, Ouwehand WH |
| |
|
Afinion™ AS100 Analyzer – a Multi-Assay System Including a New PT-INR Test
|
| Brynildsrud T, Janson T |
| |
|
Age May Modify the Relationship Between Factor V Leiden Mutation: but not G20210A Prothrombin Gene Variation: and Idiopathic Venous Thromboembolism: An Hospital-Based Case-Control Study
|
| Le Gal G, Lacut K, Couturaud F, Mercier B, Bressollette L, Leroyer C, Mottier D, Oger E |
| |
|
Age-Related Effects of Regular Physical Activity on Coagulation Factors in Men
|
| Sugawara J, Hayashi1 K, Tanaka T, Yokoi T, Kurachi S, Kurachi K |
| |
|
Aggravation of Quality of Life for Patients with Ischaemic Heart Disease and Chronic Atrial Fibrillation on Oral Anticoagulation Therapy: Experience in Lithuania
|
| Kriukelyte D, Tamosiuniene R |
| |
|
Agonist Dependence of the Platelet Secretome
|
| Owen WG, Charlesworth MC, Muddiman DC |
| |
|
Alanine Mutagenesis Demonstrates Functional Importance of Four Amino Acids Within the Disintegrin Eristostatin: Implications for Its Anti-Platelet and Anti-Cancer Properties
|
| McLane MA, Zhang X, Tian J, Zelinskas C, Srivastava A, Paquette-Straub CA |
| |
|
Albumin Mildly Oxidized by the Myeloperoxidase Product Hypochlorous Acid Strongly Activates Platelets and Monocytes Via CD36
|
| Brodde MF, Volf I, Jurk K, Kehrel BE |
| |
|
Alignment of Factor V Sequences in Twelve Mammalian Species Shows Several Strongly Conserved Motifs in the B-Domain
|
| Vos HL |
| |
|
Alloantigenic Polymorphisms of the b–Terminal Domain Impair the Function of Platelet aIIbb3 Integrin
|
| Hartmut K, Sentot S |
| |
|
Alpha Granule formation in Megakaryocytes and Platelets Requires VPS33B, A Member of the Sec1/Munc18 (SM) Protein Family
|
| Kahr WHA, Li L, Christensen H, Ye C, Gissen P, Chitayat D, Lo B |
| |
|
Alteration of Protein Z in Cardio-Cerebra Thrombotic Diseases and Its Significance
|
| Pan X-Y, Bao C-X, Zhou W-X, Huan X-M, Guo Y |
| |
|
Alteration of Protein Z in Malignant Tumors and Its Significance
|
| Shang Y, Pan X-y, Din C-P, Cai X-y, Din Y, Zhang R-L |
| |
|
Alteration of Protein Z in Patients with Uremia and Its Significance
|
| Pan X-Y, Bao C-X, Huan W-M, Chai X-Y |
| |
|
Alterations of the Tissue-Factor Induced Pathway of Coagulation during Acute Deep Vein Thrombosis (DVT): Significant Increase in Tissue-Factor Pathway Inhibitor (TFPI)
|
| SidelmannMünsterMünster JJAMBH, Bertelsen V, Mourits-Andersen T, Bladbjerg EM |
| |
|
Altered Clearance of Apoptotic Endothelial Cells in the Presence of Antiphospholipid Antibodies Provides a Dual Mechanism for Thrombosis in Antiphospholipid Syndrome
|
| Morrison ER, Ford I, Erwig LP, Barker RN, Greaves M |
| |
|
Alternative Clinical Diagnoses with Spiral CT in Patients with Suspected Pulmonary Embolism
|
| Sohne M, Smit AA, van Rijn JC, van Delden OM, Buller HR, Bresser P |
| |
|
Alternatively Spliced Soluble Tissue Factor in Mice
|
| Brüggemann LW, Drijfhout JW, Reitsma PH, Spek CA |
| |
|
Amblyomma Cajennense Tick: The Transcriptome, Expression and Biochemical Characterization of a Factor Xa Recombinant Inhibitor
|
| Batista IFC, Junqueira-de-Azevedo ILM, Faria F, Simons SM, Maria DA, Ho PL, Chudzinski-Tavassi AM |
| |
|
Ambulatory Therapy of Patients with Free-Floating Proximal Deep Vein Thrombosis Is Safe
|
| Ramasamy K, Patel RK, Goss D, Deane C, Lambie J, Bonner L, Arya R |
| |
|
Amiloride Inhibits Urokinase Type Plasminogen Activator-Mediated Proteolytic Activity and Increases Plasminogen Activator Inhibitor Type-1 mRNA Expression in Aortic Vascular Smooth Muscle Cells
|
| Nguyen R, Liu HB, Dear AE |
| |
|
Amino Acid Polymorphisms in the a Domains of von Willebrand Factor: Frequencies in the South Wales Population of the UK and Effect on Proteolysis By ADAMTS13
|
| Bowen DJ |
| |
|
An Antibody Fragment Against Factor VIII That inhibits Factor VIII assembly with von Willebrand Factor and LDL Receptor Family Members
|
| Limburg V, van der Zwaan C, Boertjes RC, Bovenschen N, Mertens K, Meijer AB |
| |
|
An Approach to Elucidate the Platelet Membrane Proteome
|
| Moebius J, Zahedi PR, Lewandrowski U, Walter U, Sickmann A |
| |
|
An Audit on D-dimer Use in the Assessment of Patients with Suspected Acute Pulmonary Embolism
|
| Yong T, Hedger S, Gallus A, Coghlan D |
| |
|
An Early-Activated Gene (6A3-5) Implicated in the Control of Vascular Smooth Muscle Cell Functions
|
| Garin G, Zibara K, Aguilar F, Lo M, Hurlstone A, Poston R, Mcgregor JL |
| |
|
An Endothelial Cell-specific Regulatory Mutation In Galgt2 Is the Major Cause of Prolonged aPTT in Mice
|
| Johnsen J, Levy G, Ginsburg D |
| |
|
An Evaluation of Heparin Platelet Factor 4 Antibody Testing
|
| Smythe MA, Koerber JM, Mattson JC |
| |
|
An Evaluation of the New ACL TOP Coagulation Autoanalyser
|
| Wheeler M, Butler J, Jaskolowski S, Malan E, Gan TE |
| |
|
An Evaluation of Unfractionated Heparin Use to Assess the Magnitude of Risk For Heparin Induced Thrombocytopenia
|
| Koerber JM, Smythe MA, Szczesiul J |
| |
|
An Innovative Method to Measure von Willebrand Factor Activity and Adamts13
|
| Lattuada A, Preda L, Gallo L, Russo U, Rossi E |
| |
|
An Inquiry into Death Causes Based on Autopsy Findings
|
| Makris PE, Papamichos SI, Boutou AK, Boukas AE, Tsoukas DD, Triantaphilou A, Tsougas M, Girtovitis F, Ioannidis G, Vasiliadis N, Dougou-Tzaou S, Psaroulis D |
| |
|
An Open-Label Study Evaluating the Safety and Efficacy of Long-Term Dosing of AMG 531 in Thrombocytopenic Subjects with Immune (Idiopathic) Thrombocytopenic Purpura
|
| Bussel J, Kuter D, Aledort L, George J, Lyons R, Wasser J, Lichtin A, Nieva J, Kelly R, Chen C-F, Nichol JL |
| |
|
An Oral, Direct Factor Xa Inhibitor – BAY 59-7939 – for Prophylaxis against Venous Thromboembolism after Total Knee Replacement: A Dose-ranging Study
|
| Turpie AGG, Fisher WD, Bauer K, Kwong L, Gent M, Misselwitz F |
| |
|
An Unusual Clustering of S1506Lmutation in Type 2A von Willebrand Disease Seen in Taiwan
|
| Shen M-C, Lin H-Y, Chang C-S, Chung C-Y, Lin B, Kuo S-H, Lin J-S |
| |
|
An Unusual Factor VIII Inhibitor Developing in a Patient with Mild Hemophilia A
|
| Stoffman JM, Houston DS |
| |
|
Anaemia in Injecting Drug Users (IDU) with Deep Vein Thrombosis (DVT)
|
| Dawson DJ, Shiach CR, Mackway-Jones K, Peters L |
| |
|
Analyses of the Interaction of Platelet Collagen Receptor Glycoprotein (GP) VI with Various Types of Collagen
|
| Jung SM, Takemura Y, Miura Y, Imamura Y, Hayashi T, Adachi E, Moroi M |
| |
|
Analysis of Bleeding Score in Type 1 VWD Families in the MCMDM-1 Study
|
| Tosetto A, Castaman G, Peake I, Goodeve A, Rodeghiero F, Federici A, Batlle J, Meyer D, Mazurier C, Goudemand J, Fressinaud E, Eikenboom J, Schneppenheim R, Budde U, Ingerslev J, Vorlova Z, Habart D, Holmberg L, Lethagen S, Pasi J, Hill F |
| |
|
Analysis of Blood Coagulation in Mice: Pre-analytical Conditions and Comparison of a Home-made Assay for Thrombin-antithrombin Complexes with Two Commercial Assays
|
| Sommeijer DW, van Oerle R, Reitsma PH, Timmerman JJ, Meijers JCM, Spronk HMH, ten Cate H |
| |
|
Analysis of Combination Anti-Angiogenesis Therapy on Markers of Coagulation, Platelet Activation and Angiogenesis in Patients with Advanced Cancer
|
| Caine GJ, Harris AL, Christodoulos K, Lip GYH, Blann AD |
| |
|
Analysis of Factor VIII Gene Intron 1 Inversion in Brazilian Patients with Severe Haemophilia A
|
| Pio SF, Zouain D, Rezende SM |
| |
|
Analysis of Free Thiols During Von Willebrand Factor Biosynthesis: Implications for the Oxidoreductase Mechanism of Multimerization
|
| Purvis AR, Huang R-H, Kapadia M, Sadler JE |
| |
|
Analysis of Gas6 in Human Platelets and Plasma
|
| Balogh I, Hafizi S, Stenhoff J, Hansson K, Dahlbäck B |
| |
|
Analysis of Plasma Proteins Bound to Catheter Surfaces
|
| Thong B, Berry LR, Chan AKC |
| |
|
Analysis of the Differential Expression of uPA, PAI-1, and Tissue Kallikreins hk5, 6, 7, 8, 10, 11, 13 between Primary Ovarian Carcinoma Tissues and Corresponding Omentum Metastases
|
| Schmitt M, Kates R, Dorn J, Scorilas A, Grass L, Soosaipillai A, Diamandis E, Kiechle M, Schmalfeldt B, Harbeck N |
| |
|
Analysis of the Interaction of Platelet Collagen Receptors with Collagen Type I
|
| Kralisz U, Stasiak M |
| |
|
Analytical Evaluation of a Fully Automated Chromogenic Assay for the Determination of Endogenous Thrombin Potential (ETP)
|
| Siegemund A, Peetz D, Merz M, Henckel T, Engelhardt W |
| |
|
Analytical Performance of the New HemosIL D-Dimer HS Assay That Overcomes the Rheumatoid Factor (RF) Interference
|
| ArzaSánchez BT, Sales M |
| |
|
Analytical Performances of a New Screening Assay to Evaluated the Functionality of the Protein C Anticoagulant Pathway, and Effect of Pre-Analytical Variables on the Test Result
|
| Toulon PA, Bouziane K |
| |
|
Anamnestic Responses in Hemophilia Patients with Inhibitors on Continuous Prophylaxis with Factor Eight Inhibitor Bypassing Activity, Vapor Heated (FEIBA VH)
|
| Ewing N |
| |
|
Angiogenesis Update 2005: How Tumors Make Bad Blood Vessels
|
| Nagy JA, Dvorak AM, Dvorak HF |
| |
|
Angiographic Documentation of the Efficacy of Recombinant Activated Factor VII (Novo Seven) to Control Diffuse Bleeding in Major Trauma
|
| Hermans C, Van Der Schueren B, Hammer F, Verschuren F, Hantson P, Deneys V |
| |
|
Angiopoietin-1 and Angiopoietin-2 in Diabetes Mellitus: Relationship to VEGF, Glycaemic Control, Endothelial Damage/Dysfunction and Atherosclerosis
|
| Lim HS, Lip GYH, Blann AD |
| |
|
Angiotensin 1–9 (Ang-1-9), Similarly to Angiotensin II (Ang II), Increases Blood Pressure and Enhances Thrombosis in Hypertensive Rats
|
| Mogielnicki A, Kramkowski K, Chabielska E, Buczko W |
| |
|
Angiotensin Receptor 2 Over-Expression in Bradykinin B2 Receptor Knockout Mice Produces Thromboprotection
|
| Schmaier AH, Mahdi F, Warnock M, Srikanth S, Krijanovski Y, Murphey LJ, Madar Z |
| |
|
Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers Drug Use and the Risk of Venous Thromboembolism: Results of an Ongoing Hospitalized-Based Case–Control Study
|
| Lacut K, Le Gal G, Descourt R, Couturaud F, Leroyer C, Mottier D, Oger E |
| |
|
Annexin A5 Regulates the Engulfment Protein Repertoire on the Membrane of PS Expressing Apoptotic Cells
|
| Kenis H, van Genderen H, Deckers NM, Lux PAG, Hofstra L, Reutelingsperger CPM |
| |
|
Antagonism of TxA2 Receptor Plays a Major Role in the Inhibitory Effect of Flavonoids in Platelet Function
|
| Guerrero JA, Lozano ML, Castillo J, Benavente-García O, Martinez C, Vicente V, Rivera J |
| |
|
Anti Factor VIII Inhibitor: A Single Institution Experience
|
| Grosso S, Casais P, Blanco A, Sanchez Luceros A, Turdo K, Meschengieser S, Lazzari M |
| |
|
Anti-b2 Glycoprotein I (b2GPI) and Anti-Annexin A2 Antibodies Stimulate the Release of Microparticles from Endothelial Cells
|
| Zhang JW, McCrae BA, Lieske KA, Kyei M, McCrae KR |
| |
|
Antiaggreganting Agents Do Not Influence the Sonoclot Profile
|
| Paniccia R, Tellini I, Costanzo M, Ferrini S, Bolli P, Valente S, Giglioli C, Lombardi A, Gensini GF, Prisco D, Abbate R |
| |
|
Anti-Angiogenic Action of Peroxisome Proliferator-Activated Receptor(PPAR)g Ligands Through Cox-2-Mediated MMP-9 Expression and Release
|
| Scoditti E, Massaro M, Montinari MR, Carluccio MA, Storelli C, Distante A, De Caterina R |
| |
|
Antiapoptotic Activity of Vascular Endothelial Growth Factor (VEGF) Is also Mediated by VEGF Induced Pro-urokinase (Pro-uPA) Activation
|
| Prager GW, Koschelnick Y, Leitner K, Brunner P, Binder BR |
| |
|
Antibodies Against the Human Platel et al. loantigen (HPA)-1a impair Cell Adhesion to Fibrinogen
|
| Kroll H, Penke G, Panzer S, Santoso S |
| |
|
Antibodies to Phospholipid Cofactor Proteins Inhibit Their Binding to High Affinity Plps But Strongly Enhance Their Binding to Low Affinity Plps
|
| Amiral J, Vissac AM |
| |
|
Antibody to C1 Domain of Factor VIII Alters Interaction of Factor Xase Complex with Factor X
|
| Gilbert GE, Bhimavarapu A, Price P, Jacquemin M |
| |
|
Anticardiolipin Antibodies (ACL), Factor V Leiden (FVL) and G20210A Prothrombin Mutation (G20210AII) Do Not Predispose Renal Transplant Recipients to Thrombotic Complications or Graft Loss
|
| Rocha LKA, Castillo V, Pestana JOM, Vaz MLS, Ozaki KS, Andrade LEC, Amaral RQ, Nogutti MAE, Lourenço DM |
| |
|
Anticardiolipin Antibodies and Risk for Venous Thrombosis in a Population-Based Prospective Study
|
| Næss IA, Christiansen SC, Holmen J, Cannegieter SC, Rosendaal FR, Hammerstrøm J |
| |
|
Anti-coagulant Activity of TGN 255, a Novel Synthetic Direct Thrombin Inhibitor
|
| Chahwala S, Chander C, Dupe R |
| |
|
Anticoagulant Adverse Events in a Major City Hospital
|
| Flounders K, Nurse T, Baker R |
| |
|
Anticoagulant and Anti-inflammatory Effects of Recombinant Human Antithrombin in Man after LPS Challenge
|
| Leitner JM, Firbas C, Reiter R, Steinlechner B, Mayr FB, Jilma B |
| |
|
Anticoagulant and Antiplatelet Thrombin Derivative That Differentiates Macromolecular Substrates of Thrombin
|
| Hosokawa K, Ohnishi T, Kawakami A, Wakabayashi S, Koide T |
| |
|
Anticoagulant Effects and Inhibition of Thrombin Generation in Patients on Ximelagatran
|
| Harenberg J, Giese CH, Fenyvesi T, Hagedorn A, Träger I, Weiss CH |
| |
|
Anticoagulant Effects of Idraparinux Compared to Fondaparinux and Dalteparin
|
| Harenberg J, Giese CH, Hagedorn A, Träger I, Fenyvesi T |
| |
|
Anticoagulant Effects of Statins and Angiotensin-Converting Enzyme Inhibitors in Stable Patients with Coronary Artery Disease: Results of a Randomized Double Blind Study
|
| Undas A, Brummel K, Potaczek D, Stobierska-Dzierzek B, Bryniarski L, Szczeklik A, Mann K |
| |
|
Anticoagulant, Anti-inflammatory and Organoprotective Effects of BIBT 986, a Novel Dual Inhibitor of Thrombin and Factor Xa, on LPS-induced Disseminated Intravascular Coagulation and Septicemia in the Rat
|
| Wienen W, Schurer J, Priepke H, Ries UJ, Colbatzky F |
| |
|
Anticoagulation for Patients with Inferior Vena Cava Filters
|
| Billett HH, Mahesh S, Madsen EM, Kwon SJ, Jacobs LG |
| |
|
Anticoagulation Therapy in the Osteonecrosis
|
| Cavalheiro-Filho C, Rached RA, Nunes C, Prada F, Viera M, Chamone DAF |
| |
|
Anticoagulation with Danaparoid in Two Pregnant Women with Valve Prosthesis and Heparin-Induced Thrombocytopenia Type II (HIT Typ II)
|
| Gerhardt A, Scharf RE, Zotz RB |
| |
|
Anti-D Compared to IVIg for the Treatment of Immune Thrombocytopenic Purpura: A Systematic Review
|
| Bussel JB, Provan D, Sinclair CJ, Genereux MG |
| |
|
Anti-factor V Auto-Antibody after the Use of Recombinant Activated Protein C
|
| Lavigne-Lissalde G, Cochery-Nouvellon E, Mercier E, Lefrant JY, Muller L, Ripart J, Gris JC |
| |
|
Anti-fibrinolytic Use in Major Orthopaedic Surgery Reduces Allogeneic Blood Transfusion. A Meta-analysis of Randomised Trials
|
| Zufferey P, Merquiol F, Laporte S, Molliex S, Auboyer C, Decousus H, Samama CM, Mismetti P |
| |
|
Anti-FVIII Inhibitor Development in Hemophilic Mice is Dependent Upon Genetic Background, Adjuvant Type, Injection Site, and Frequency of Antigen Exposure
|
| Labelle A, Rawle F, Hough C, Lillicrap D |
| |
|
Antigen Binding Site Glycosylation Determines the Anticoagulant Activity of a Type II Factor VIII Antibody without Modifying Affinity or Epitope Specificity
|
| Jacquemin M, Lavend'homme R, Van der Elst L, Dewaele J, Collen D, Saint-Remy JM, Dewerchin M |
| |
|
Anti-Heparin/PF4 Complex Antibodies (HIT Antibodies) in Chronic Uremia Patients Requiring Hemodialysis with Heparin
|
| Kobayashi H, Wanaka K, Matsuo M, Matsuo T |
| |
|
Anti-idiotypic Monoclonal Antibodies (Anti-Id mabs) Neutralizing Anti-FVIII Antibodies (abs) Directed Towards Heavy and Light Chains Fully Protect FVIII Function
|
| Gilles JG, Grailly S, Jacquemin M, Saint-Remy J-M |
| |
|
Antiidiotypic Single Chain Fragments Specific for Inhibitors to Coagulation Factor VIII Isolated by Phage Display Screening of Polyclonal Haemophilia a Patient's Plasma
|
| Kessel C, Linde R, Kreuz W, Königs C |
| |
|
Anti-Inflammatory and Anti-Angiogenic Effects of the Omega-3 Fatty Acid Docosahexaenoate (DHA, 22:6 n-3) Through ERK1/2-Mediated Inhibition of Cyclooxygenase (COX)-2 Expression
|
| MassaroM, Scoditti E, Carluccio MA, Storelli C, Distante A, De Caterina R |
| |
|
Anti-Inflammatory and Anticoagulant Effects of Atorvastatin in Type 2 Diabetics Versus Non-Diabetics
|
| Mousa SA, Mohamed S, Kane M |
| |
|
Anti-Neutrophil Cytoplasmic Antibodies (ANCAs) Promote Leukocyte Adhesion in the Glomerular Microvasculature
|
| Hickey MJ, Kwan RYQ, Holdsworth SR |
| |
|
Antiphospholipid Antibodies and Platelet Activation as Thrombotic Risk Factors in Thrombocythemia Associated with Myeloproliferative Disorder
|
| Bidot C, Jy W, Fontana V, Ahn E, Horstman L, Ahn Y |
| |
|
Antiphospholipid Antibodies Impair the Clearance of Apoptotic Platelets
|
| Vega-Ostertag ME, Pierangeli SS |
| |
|
Antiphospholipid Antibodies in 42 Neonates Born to Mothers with the Antiphospholipid Syndrome and Included in the European Forum Register
|
| Aurousseau MH, Lachassinne E, Carbillon L, Fain O, Biasini-Rebaioli C, Derenne S, Boinot C, Schlegel N, Avcin T, Le Toumelin P, Faden D2, Piette JC, Tincani A, Uzan M, Boffa MC |
| |
|
Antiphospholipid Antibodies in Children – Reference Values in Healthy Controls and Frequency in Children with aPTT Prolongation, Thrombosis or Stroke
|
| Becker S, Müller M, Klarmann D, Figura S, Stoll H, Kreuz W |
| |
|
Antiphospholipid Antibody Syndrome (APS) Experience in the Hospital for Sick Children
|
| Komvilaisak P, Brandão L, Massicotte P, Chan AKC, Castle D, Williams S |
| |
|
Anti-phospholipid Antibody Syndrome in the Neonatal Period: Report of a Rare Case
|
| Lazarchick J, Sultan I, Brown RC |
| |
|
Antiphospholipid Syndrome and Risk of Myocardial Infarction in Young: A Preliminary Study
|
| Ben Romdhane N, Kriaa A, Ammar S, Zitouni M, Ben Lassoued MA, Bahri A, Fkih M, Chabrak S, Manai Z, Makni S, Kaabachi N, Kafsi N |
| |
|
Antiphospholipid Syndrome Secondary to Renal Cell Carcinoma in a Twelve year Old Boy
|
| Komvilaisak P, Williams S, Gerstle T, Salle JL, (Pippi), Smith CR, Grant RM |
| |
|
Antiplatelet Activity of KR-32560, a Novel Selective Sodium/hydrogen Exchanger-1 Inhibitor
|
| Yun YP, Lee KS, Yi KY, Yoo SE, Shin HS |
| |
|
Antiplatelet Effects of Hydroxyproline- and Proline-Containing Dipeptides
|
| Cherkasova K, Ashmarin I |
| |
|
Antiplatelet Treatment Does Not Affect the Kinetics of Clot Formation After TF Pathway Activation in Patients with Carotid Artery Disease. A Thromboelastography Study
|
| Kostantinidis K, Gerasimidis T |
| |
|
Antiplatelet Treatment with Aggressive Lipid Lowering Therapy and Reduction of Clinical Events after Myocardial Infarction
|
| Corinaldesi G, Corinaldesi C |
| |
|
Anti-Protein S and Anti-Phosphatidylethanolamine (aPE) Antibodies in Patients with Clinical Features of Antiphospholipid Syndrome (APS)
|
| Sanmarco M, Bardin N, Roll P, Dignat-George F, Alessi MC |
| |
|
Anti-Prothrombin Antibodies in Women with Vascular Pregnancy Complications and in Patients with Thrombosis and Suspected Antiphospholipid Syndrome (APS)
|
| Bergmann F, Kraska Y, Hempel M |
| |
|
Antithrombin Failed to Attenuate Inflammatory Responses in Congenital Calcitonin Gene-Related Peptide Deficient Mice Subjected to Hepatic Ischemia/Reperfusion
|
| Harada N, Okajima K, Uchiba M, Kurihara H, Nakagata N |
| |
|
Anti-thrombotic Action of Clopidogrel is More Pronounced in Patients with Coronary Artery Disease Carrying PlA2 Allele of Beta3 Integrin
|
| Dropinski J, Musial J, Jakiela B, Wegrzyn W, Sanak M, Szczeklik A |
| |
|
Antithrombotic Activity of a Small Molecule Factor XIa Inhibitor in Rats with Limited Effects on Bleeding Time
|
| Schumacher W, Seiler S, Steinbacher T, Stewart A, Hartl K, Liu E, Ogletree M |
| |
|
Antithrombotic Effect of Bothrojaracin, a Bothrops jararaca Snake Venom-Derived (Pro)thrombin Inhibitor
|
| Zingali RB, Ferreira MS, Assafim MIA, Frattani FS, Mendes-Silva W, Silva DM, Monteiro RQ |
| |
|
Antithrombotic Effect of the Peptide YMESRADR, Corresponding to Residues 313–320 of the Platelet aIIb Subunit in a Rabbit Model of Carotid Artery Thrombosis
|
| Papamichael ND, Russa V, Tsironis LD, Stanica RM, Kotsia A, Nikas D, Tsikaris V, Katsouras CS, Tselepis AD, Michalis LK |
| |
|
Antithrombotic Effects of a Direct Factor Xa Inhibitor, DU-176b, and an Antithrombin Dependent Factor Xa Inhibitor, Fondaparinux, on an Ex vivo Capillary Perfusion Chamber Thrombosis Model in Rats
|
| Fukuda T, Matsumoto C, Honda Y, Morishima Y, Shibano T |
| |
|
Antithrombotic Effects of Bacterial K5-Derived Sulfaminoheparosans in a Jugular Vein Crush Model of Thrombosis in Rats
|
| Cornelli U, Maddineni J, Manoni M, Iqbal O, Hoppensteadt D, Fareed J |
| |
|
Antithrombotic Effects of SCH 205831: A Potent, Selective and Orally Active Antagonist of the PAR-1 Thrombin Receptor
|
| Chintala M, Ahn H, Foster C, Xia Y, Chackalamannil S |
| |
|
Antithrombotic Effects of the Direct Factor Xa Inhibitor Razaxaban in Canine Models of Thrombosis
|
| Knabb R, Leamy A, Luettgen J, Quan M, Lam P, Wexler R, Wong P |
| |
|
Antithrombotic Mechanism of Action of BAY 59-7939 – a Novel, Oral, Direct Factor Xa Inhibitor
|
| Fareed J, Hoppensteadt D, Maddenini J, Schultz C, Neville B, Iqbal O, Perzborn E, Misselwitz F |
| |
|
Antithrombotic Mechanisms Achieved by Selective Extraction of Cholesterol from Platelet Membrane by Methyl-b-Cyclodextrin
|
| Tamura N, Ishida H, Goto S |
| |
|
Antithrombotic Porphylaxis During Pregnancy in Women with Previous Venous Thromboembolism
|
| Martinelli I, Battaglioli T, Mannucci PM |
| |
|
Antithrombotic Properties of DU-176b, a Novel Orally Active Factor Xa Inhibitor: Inhibition of both Arterial and Venous Thrombosis, and Combination Effects with Other Antithrombotic Agents
|
| Morishima Y, Furugohri T, Honda Y, Matsumoto C, Isobe K, Fukuda T, Shiozaki Y, Muramatsu S, Sugiyama N, Shibano T |
| |
|
Antithrombotic Therapy in Cancer Patients
|
| Lee AYY |
| |
|
Antithrombotic Treatment in Patients with Recurrent Miscarriage
|
| Ulander V-M, Ämmälä P, Kaaja R |
| |
|
Antithrombotics Inhibit Tumor Metastasis
|
| Brüggemann LW, Versteeg HH, Reitsma PH, Spek CA |
| |
|
Antiviral Treatment of HCV Infected Young Haemophiliacs – An Update of 12 Years Experience
|
| Koehler-Vajta K, Froesner G, Zachoval R |
| |
|
Any Relationship Between Inherited Thrombophilia and Bleeding Phenotype or Vascular Disease in Patients with Hemophilia and von Willebrand Disease?
|
| Coppola A, Cimino E, De Simone C, Cirillo F, Agnes R, Tufano A, Macarone Palmieri N, Cerbone AM, Di Minno G |
| |
|
Apaf-1 and Caspase 9 Regulate Early and Late Stages of Megakaryocyte Differentiation
|
| Debili N, Feraud O, Chang Y, Auradé F, Haond C, Cramer EM, Kroemer G, Vainchenker W |
| |
|
APC Anti-infective Action is Augmented by APC Activation of Protein C
|
| Hassouna HI, Quinn C |
| |
|
APC Resistance Caused by Prothrombin G20210A Mutation Does Not Affect the Fibrinolytic Activity of Activated Protein C
|
| Binetti BM, Asti D, Tripodi A, Semeraro N, Colucci M |
| |
|
APCC (FEIBA) Home Therapy. Long Term Use: An Italian Retrospective Survey in Hemophilia Patients with FVIII/IX Inhibitors
|
| Schino M |
| |
|
APCC (FEIBA) Home Therapy. Long Term Use: An Italian Retrospective Survey in Hemophilia Patients with FVIII/IX Inhibitors
|
| Schino M |
| |
|
APC-PCI Complex Concentration and Association with Factor V Leiden in Patients with Deep Vein Thrombosis
|
| Strandberg K, Nilsson C, Stenflo J, Svensson P |
| |
|
Apical Sorting of ADAMTS13 in Madin-Darby Canine Kidney (MDCK) Cells Depends on an Association with Detergent-Insoluble Sphingolipid and Cholesterol-Enriched Rafts
|
| Shang D, Ai J, Li N, Zheng X |
| |
|
Apoptosis of Monocytes Reduces Their Interaction with P-Selectin Expressing Platelets Under Flow Conditions by Disruption of the Interaction of PSGL-1 with the Actin Cytoskeleton
|
| Van Genderen H, Wielders S, Lindhout T, Reutelingsperger C |
| |
|
Apoptotic Mechanisms Underlying High-Risk Plaque
|
| Clarke MC, Stoneman VEA, Braganza DM, Figg N, Cutter J, Littlewood TD, Allard DA, Bennett MR |
| |
|
Application of Filtration Technologies for Prion Removal from Plasma Product Intermediates
|
| Pham H, Seyfert-Brand W, Alaveras M, Wiegand T, Gnau O, Schäfer W, Gröner A, Martinelli T |
| |
|
Applications of Thrombin Generation Assay in Characterizing FVIII Bypassing Agents
|
| Váradi K, Binder BR, Turecek PL |
| |
|
Are Diagnostic Algorithms for Suspected Pulmonary Embolism Applicable in French Emergency Departments?
|
| Roy PM, Furber A, Roupie E, Honnart D, Soulat L, Meyer G |
| |
|
Are Discard Tubes Needed for PT and APTT Assays? |
